Thouinia paucidentata
Thouinia paucidentata · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Thouinia paucidentata is a botanical species that has garnered scientific interest due to its potential medicinal properties. Recent investigations have focused specifically on the leaf extract of this plant to evaluate its biological activities. Researchers are examining its efficacy against various pathogens, including the bacteria Acinetobacter baumannii and Pseudomonas aeruginosa. Furthermore, the extract is being studied for its potential impact on protozoan infections such as Cutaneous Leishmaniasis caused by Leishmania mexicana. This study aims to characterize the antimicrobial potential inherent in the plant's leaves.
- Synonyms
- Not available
- Common names
- Not available
- Family
- Sapindaceae
- Distribution
- Not available
- Plant Parts
- Leaf
Classification
Taxonomy
Thouinia paucidentata is a distinctive member of the kingdom Plantae. Within this vast biological realm, it is specifically classified under the class Equisetopsida. The species belongs to the order Sapindales, which connects it to a diverse group of flowering plants. It further falls into the family Sapindaceae, showcasing its specialized evolutionary traits. Ultimately, this plant is defined by its placement within the genus Thouinia.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Sapindales |
| Family | Sapindaceae |
| Genus | Thouinia |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Thouinia paucidentata maintains an expansive geographic footprint that stretches across much of the Americas. In North America, the species is widely distributed throughout various regions of Mexico, including the central, southeast, and southwest territories. Its range extends significantly southward into the lush landscapes of Central America. Specifically, the plant can be found thriving within the borders of both Belize and Guatemala. This broad distribution highlights the plant's ability to adapt to diverse ecological niches across multiple countries.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Thouinia paucidentata is a self-supporting plant that takes the form of a tree. Reaching a maximum height of 12 meters, it establishes a sturdy presence within its ecosystem. This growth habit allows it to thrive as a structural component of the forest canopy.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Thouinia paucidentata serves as a significant subject in the study of Mayan medicinal plants due to its potent anti-infective properties. Recent chemical analyses of its leaf extracts have revealed a complex profile of bioactive phytoconstituents. Specifically, the plant contains fatty acids that play a crucial role in its biological activity. Furthermore, the presence of terpenes has been identified as a key contributor to the plant's ability to combat resistant bacteria. These findings highlight the therapeutic potential of the species in developing new treatments against high-priority pathogens.
Conditions
Thouinia paucidentata exhibits significant anti-infective properties against several high-priority pathogens and diseases. Research demonstrates that leaf extracts of this plant can effectively treat carbapenem-resistant Acinetobacter baumannii by dramatically reducing imipenem MIC levels. It also shows medicinal potential in combating the bacteria Pseudomonas aeruginosa. Furthermore, the plant acts as an anti-Leishmania phytomedicine by demonstrating potent activity against Leishmania mexicana. These therapeutic effects support the traditional Mayan medicinal use of the plant for treating cutaneous leishmaniasis.
Preparations
Thouinia paucidentata is prepared as a leaf extract to investigate its medicinal potential against antibiotic-resistant bacteria. This specific preparation was utilized in the study to assess its ability to inhibit the growth of critical pathogens like Acinetobacter baumannii. The resulting leaf extract demonstrated a significant capacity to reduce the imipenem MIC by 2048-fold for carbapenem-resistant strains. By employing n-hexane for the extraction process, researchers were able to isolate non-polar phytoconstituents from the plant material. These extracted compounds are now being viewed as valuable resources for developing novel anti-infective therapies.
Parts used
Thouinia paucidentata serves as a significant subject in recent pharmacological research focused on combating antibiotic-resistant bacteria. Specifically, the leaf of this Mayan medicinal plant was utilized to create extracts for testing against critical pathogens. Scientific results demonstrated that the leaf extract of this species could remarkably reduce the imipenem MIC for carbapenem-resistant Acinetobacter baumannii by 2048-fold. Through GC-MS analysis, researchers identified various phytoconstituents like terpenes and fatty acids within these extracts that contribute to such potent anti-infective properties. This study underscores the immense potential of utilizing specific plant parts to develop novel therapies against high-priority bacterial threats.